stars 1 stars 2 stars 3

The Company is currently moving towards commercialisation stage with two revolutionary products, these being a physiological treatment for depression using transcranial magnetic stimulation (TranQuality), along with a bespoke electrospun polymer blend for the treatment of stress urinary incontinence (Symimetic) which results from pelvic organ prolapse. To find out more info please follow link below

INTERMEDI GROUP Questions

The INTERMEDI GROUP annual revenue was $1 million in 2026.

The NAICS codes for INTERMEDI GROUP are [339, 33].

The SIC codes for INTERMEDI GROUP are [38, 384].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users